chr7-87941395-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001324418.2(ADAM22):​c.246+6209G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.989 in 152,308 control chromosomes in the GnomAD database, including 74,491 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.99 ( 74491 hom., cov: 32)

Consequence

ADAM22
NM_001324418.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.564

Publications

6 publications found
Variant links:
Genes affected
ADAM22 (HGNC:201): (ADAM metallopeptidase domain 22) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. Unlike other members of the ADAM protein family, the protein encoded by this gene lacks metalloprotease activity since it has no zinc-binding motif. This gene is highly expressed in the brain and may function as an integrin ligand in the brain. In mice, it has been shown to be essential for correct myelination in the peripheral nervous system. Alternative splicing results in several transcript variants.[provided by RefSeq, Dec 2010]
ADAM22 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 61
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.988 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001324418.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAM22
NM_001324418.2
MANE Select
c.246+6209G>A
intron
N/ANP_001311347.1H7C3I4
ADAM22
NM_001324419.2
c.243+6209G>A
intron
N/ANP_001311348.1
ADAM22
NM_001391975.1
c.246+6209G>A
intron
N/ANP_001378904.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAM22
ENST00000413139.2
TSL:5 MANE Select
c.246+6209G>A
intron
N/AENSP00000412085.2H7C3I4
ADAM22
ENST00000265727.11
TSL:1
c.246+6209G>A
intron
N/AENSP00000265727.7Q9P0K1-1
ADAM22
ENST00000398209.7
TSL:1
c.246+6209G>A
intron
N/AENSP00000381267.3Q9P0K1-2

Frequencies

GnomAD3 genomes
AF:
0.989
AC:
150518
AN:
152190
Hom.:
74431
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.997
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.993
Gnomad ASJ
AF:
0.997
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.996
Gnomad FIN
AF:
0.986
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
0.982
Gnomad OTH
AF:
0.993
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.989
AC:
150637
AN:
152308
Hom.:
74491
Cov.:
32
AF XY:
0.989
AC XY:
73671
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.997
AC:
41421
AN:
41566
American (AMR)
AF:
0.993
AC:
15182
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.997
AC:
3462
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5182
AN:
5184
South Asian (SAS)
AF:
0.996
AC:
4809
AN:
4828
European-Finnish (FIN)
AF:
0.986
AC:
10467
AN:
10614
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
0.982
AC:
66813
AN:
68036
Other (OTH)
AF:
0.993
AC:
2096
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
89
179
268
358
447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.985
Hom.:
9640
Bravo
AF:
0.991
Asia WGS
AF:
1.00
AC:
3477
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.80
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs470; hg19: chr7-87570710; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.